| Literature DB >> 28148735 |
Veron Ramsuran1,2, Pedro G Hernández-Sanchez1,3, Colm O'hUigin1, Gaurav Sharma4,5, Niamh Spence1,5, Danillo G Augusto6, Xiaojiang Gao1, Christian A García-Sepúlveda3, Gurvinder Kaur4, Narinder K Mehra4, Mary Carrington7,2.
Abstract
Polymorphisms located within the MHC have been linked to many disease outcomes by mechanisms not yet fully understood in most cases. Variants located within untranslated regions of HLA genes are involved in allele-specific expression and may therefore underlie some of these disease associations. We determined sequences extending nearly 2 kb upstream of the transcription start site for 68 alleles from 57 major lineages of classical HLA class I genes. The nucleotide diversity within this promoter segment roughly follows that seen within the coding regions, with HLA-B showing the highest (∼1.9%), followed by HLA-A (∼1.8%), and HLA-C showing the lowest diversity (∼0.9%). Despite its greater diversity, HLA-B mRNA expression levels determined in 178 European Americans do not vary in an allele- or lineage-specific manner, unlike the differential expression levels of HLA-A or HLA-C reported previously. Close proximity of promoter sequences in phylogenetic trees is roughly reflected by similarity of expression pattern for most HLA-A and -C loci. Although promoter sequence divergence might impact promoter activity, we observed no clear link between the phylogenetic structures as represented by pairwise nucleotide differences in the promoter regions with estimated differences in mRNA expression levels for the classical class I loci. Further, no pair of class I loci showed coordinated expression levels, suggesting that distinct mechanisms across loci determine their expression level under nonstimulated conditions. These data serve as a foundation for more in-depth analysis of the functional consequences of promoter region variation within the classical HLA class I loci.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28148735 PMCID: PMC5340644 DOI: 10.4049/jimmunol.1601679
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422